BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16776266)

  • 1. [Wolman disease].
    Tanaka A
    Nihon Rinsho; 2006 May; Suppl 1():750-2. PubMed ID: 16776266
    [No Abstract]   [Full Text] [Related]  

  • 2. [Wolman disease and cholesteryl ester storage disease].
    Tanaka A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():337-40. PubMed ID: 11347090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acid lipase deficiency (Wolman disease and cholesteryl ester storage disease: CESD)].
    Tanaka A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):427-30. PubMed ID: 9645100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].
    Tanaka A
    Nihon Rinsho; 1995 Dec; 53(12):3004-8. PubMed ID: 8577049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis.
    Reynolds T
    J Clin Pathol; 2013 Nov; 66(11):918-23. PubMed ID: 23999269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role and mechanism of lysosomal acid lipase activity].
    Piskorska D; Kopieczna-Grzebieniak E
    Przegl Lek; 1988; 45(8):637-40. PubMed ID: 3070642
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol ester storage disease with unusual neurological manifestations in two siblings: a report from South India.
    Bindu PS; Taly AB; Christopher R; BharatKumar PV; Panda S; Netravathi M; Ravishankar S; Mahadevan A; Yasha TC; Gayathri N
    J Child Neurol; 2007 Dec; 22(12):1401-4. PubMed ID: 18174560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
    Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
    Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New diagnostic method for lysosomal acid lipase deficiency and the need to recognize its manifestation in infants (Wolman disease).
    Gómez-Nájera M; Barajas-Medina H; Gallegos-Rivas MC; Mendez-Sashida P; Goss KA; Sims KB; Tripuraneni R; Valles-Ayoub Y
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):e22-4. PubMed ID: 24048164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipidemia in patients with hyperuricemia].
    Yamamoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():743-7. PubMed ID: 11347166
    [No Abstract]   [Full Text] [Related]  

  • 11. In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3.
    Anderson RA; Rao N; Byrum RS; Rothschild CB; Bowden DW; Hayworth R; Pettenati M
    Genomics; 1993 Jan; 15(1):245-7. PubMed ID: 8432549
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice.
    Du H; Heur M; Witte DP; Ameis D; Grabowski GA
    Hum Gene Ther; 2002 Jul; 13(11):1361-72. PubMed ID: 12162818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal Acid Lipase Deficiency: Therapeutic Options.
    Pastores GM; Hughes DA
    Drug Des Devel Ther; 2020; 14():591-601. PubMed ID: 32103901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency.
    Zhang B; Porto AF
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):682-5. PubMed ID: 23403440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
    Porto AF
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
    Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
    World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wolman disease with novel mutation of LIPA gene in a Chinese infant].
    Huang YL; Sheng HY; Zhao XY; Yu JK; Li L; Liu HS; Gu CM; He DM; Liu L
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):601-5. PubMed ID: 23158738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural bases of Wolman disease and cholesteryl ester storage disease.
    Saito S; Ohno K; Suzuki T; Sakuraba H
    Mol Genet Metab; 2012 Feb; 105(2):244-8. PubMed ID: 22138108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting cell type-specific impact in lysosomal acid lipase deficiency-associated disorders.
    Westerterp M; Li F; Zhang H
    J Lipid Res; 2023 Dec; 64(12):100474. PubMed ID: 37972729
    [No Abstract]   [Full Text] [Related]  

  • 20. Intragenic deletion as a novel type of mutation in Wolman disease.
    Lee TM; Welsh M; Benhamed S; Chung WK
    Mol Genet Metab; 2011 Dec; 104(4):703-5. PubMed ID: 21963785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.